Combined Associations of Glycoprotein Acetylation With Lipoprotein (a) and hs‐CRP (High‐Sensitivity C‐Reactive Protein) on Risk of Cardiovascular Disease in MESA
Journal of the American Heart Association · 20.10.2026 · 15 (20)
DOI: 10.1161/jaha.125.048493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 20.10.2026. Verfasst von Parveen K Garg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology University of Southern California Los Angeles CA. Hauptthemen laut MEDLINE: C-Reactive Protein, Lipoprotein(a), Cardiovascular Diseases, Glycoproteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Higher plasma glycoprotein acetylation (GlycA) concentrations are associated with an increased risk for incident cardiovascular disease (CVD). We investigated the combined associations of GlycA with lipoprotein (a) (Lp[a]) and hs‐CRP (high‐sensitivity C‐reactive protein) with incident CVD.
Methods
We followed 6676 MESA (Multi‐Ethnic Study of Atherosclerosis) participants, aged 45 to 84 years, without baseline CVD. Lp(a), GlycA, and hs‐CRP were evaluated categorically using standard cut points (Lp[a]: 50 mg/dL; GlycA: 400 μmol/L; hs‐CRP: 2 mg/L). We used multivariable‐adjusted Cox hazards models to evaluate individual and combined associations of these 3 biomarkers with incident CVD, coronary heart disease, and stroke.
Results
Compared with those with low GlycA and low Lp(a) levels, an increase in both incident CVD and coronary heart disease risk was observed for those participants with high levels of either or both of these biomarkers. Risk was highest for those with both high GlycA and high Lp(a) levels (CVD hazard ratio [HR]=1.55 [95% CI: 1.15–2.10) and coronary heart disease (HR=1.92 [95% CI, 1.33–2.77). A similar pattern was not observed for individuals with high levels of both GlycA and hs‐CRP. Compared with participants with low levels of GlycA, Lp(a), and hs‐CRP, those with high levels of all 3 biomarkers had a 1.98‐fold higher CVD risk (95% CI, 1.39–2.82), a 2.23‐fold higher coronary heart disease risk (95% CI, 1.45–3.44), and a 2.51‐fold higher stroke risk (95% CI, 1.24–5.08).
Conclusions
Routine assessment of GlycA in addition to Lp(a) and hs‐CRP may help to identify individuals at particularly increased CVD risk who may benefit from more aggressive preventive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology University of Southern California Los Angeles CA.
- Division of Biostatistics and Health Data Science University of Minnesota School of Public Health Minneapolis MN.
- Department of Laboratory Medicine and Pathology University of Minnesota Minneapolis MN.
- NMR Diagnostics Research and Development Labcorp Morrisville NC.
- Division of Cardiovascular Medicine University of California San Diego La Jolla CA.
ORCID-Profile: Parveen K Garg, Weihua Guan, James D Otvos, Margery A Connelly, Harpreet S Bhatia, Amy B Karger, Michael Y Tsai
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Garg, P. K., Guan, W., Nomura, S., Otvos, J. D., Connelly, M. A., Bhatia, H. S., Karger, A. B., & Tsai, M. Y. (2026). Combined Associations of Glycoprotein Acetylation With Lipoprotein (a) and hs‐CRP (High‐Sensitivity C‐Reactive Protein) on Risk of Cardiovascular Disease in MESA. Journal of the American Heart Association, 15(20). https://doi.org/10.1161/jaha.125.048493
Vancouver
Garg PK, Guan W, Nomura S, Otvos JD, Connelly MA, Bhatia HS, et al. Combined Associations of Glycoprotein Acetylation With Lipoprotein (a) and hs‐CRP (High‐Sensitivity C‐Reactive Protein) on Risk of Cardiovascular Disease in MESA. Journal of the American Heart Association. 2026;15(20). doi:10.1161/jaha.125.048493
BibTeX
@article{Garg2026,
author = {Garg, Parveen K and Guan, Weihua and Nomura, Sarah and Otvos, James D and Connelly, Margery A and Bhatia, Harpreet S and Karger, Amy B and Tsai, Michael Y},
title = {Combined Associations of Glycoprotein Acetylation With Lipoprotein (a) and hs‐CRP (High‐Sensitivity C‐Reactive Protein) on Risk of Cardiovascular Disease in MESA},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {20},
doi = {10.1161/jaha.125.048493}
}
EUVIMED